{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:51:17Z","timestamp":1792068677955,"version":"4.4.0"},"reference-count":49,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["CPT Pharmacom &amp;amp; Syst Pharma"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Physiologically based pharmacokinetic (PBPK) models are increasingly used in pediatric drug development and matching such models to the target population is an important consideration. A US pediatric PBPK model was developed incorporating four sub\u2010groups describing physiology and enzymatic\/transporter levels for White, African American, Hispanic\/Latino and Asian subjects. Virtual populations could then be created reflecting the demographics of the clinical study design. Ten different drugs (14 studies) were used to verify the pediatric PBPK model performance. Predicted PK parameters showed reasonable agreement with observed data, 50% of the predicted: observed values were within 0.8\u20131.25\u2010fold, 74% within 0.67\u20131.5\u2010fold, and 97% within 0.5\u20132\u2010fold. There was minimal difference for most drugs in performance between the mixed US and North European pediatric populations. This was partly due to reported studies having low numbers of subjects and under\u2010representation of some ethnicities. Power calculations showed that to detect a pharmacokinetic difference for the CYP3A4\/5 substrates midazolam, sirolimus and tacrolimus between African American and White American children with a power of 80%, 25, 18 and 12 subjects respectively, in each group would be needed. Developing adult and pediatric PBPK models to closely match study populations is important due to their increased regulatory use and with the move to their application in personalized medicine. Such models may also help to bridge some of the ethnic differences not captured in pediatric clinical studies due to the low numbers of subjects.<\/jats:p>","DOI":"10.1002\/psp4.70344","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:54:22Z","timestamp":1790222062000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development, Early Verification and Application of a North American Pediatric\n                    <scp>PBPK<\/scp>\n                    Model, Comparison With the North European Pediatric Population"],"prefix":"10.1002","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0778-0081","authenticated-orcid":false,"given":"Trevor N.","family":"Johnson","sequence":"first","affiliation":[{"name":"Certara Predictive Technologies  Sheffield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiskani","family":"Kondowe","sequence":"additional","affiliation":[{"name":"Mathematical Sciences University of Malawi  Zomba Malawi"},{"name":"Division of Population Health, School of Health Sciences, Centre for Biostatistics University of Manchester  Manchester UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3584-2318","authenticated-orcid":false,"given":"Joyce","family":"van der Heijden","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Pharmacology and Toxicology Radboud University Medical Center  Nijmegen the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0502-0647","authenticated-orcid":false,"given":"Saskia N.","family":"de Wildt","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Pharmacology and Toxicology Radboud University Medical Center  Nijmegen the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Gardner","sequence":"additional","affiliation":[{"name":"Certara Predictive Technologies  Sheffield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7020-1970","authenticated-orcid":false,"given":"Karen Rowland","family":"Yeo","sequence":"additional","affiliation":[{"name":"Certara Predictive Technologies  Sheffield UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.890"},{"key":"e_1_2_9_3_1","unstructured":"E.Jensen N.Jones M.Rabe et\u00a0al. \u201c2020 U.S. Population More Racially and Ethnically Diverse Than Measured in 2010 \u201d2021 accessed March 18 2026 https:\/\/www.census.gov\/library\/stories\/2021\/08\/2020\u2010united\u2010states\u2010population\u2010more\u2010racially\u2010ethnically\u2010diverse\u2010than\u20102010.html."},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1970"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.conctc.2024.101331"},{"key":"e_1_2_9_6_1","unstructured":"US Food and Drug Administration (FDA) \u201cDiversity Plan to Improve Enrolment of Participants From Under\u2010Represented Populations in Clinical Studies \u201d2024 accessed March 18 2026 https:\/\/www.fda.gov\/regulatory\u2010information\/search\u2010fda\u2010guidance\u2010documents\/diversity\u2010action\u2010plans\u2010improve\u2010enrollment\u2010participants\u2010underrepresented\u2010populations\u2010clinical\u2010studies."},{"key":"e_1_2_9_7_1","unstructured":"ICH \u201cGuideline E5: Ethnic Factors in the Acceptability of Foreign Clinical Data \u201dICH 1998 accessed March 18 2026 https:\/\/www.ema.europa.eu\/en\/ich\u2010e5\u2010r1\u2010ethnic\u2010factors\u2010acceptability\u2010foreign\u2010clinical\u2010data\u2010scientific\u2010guideline."},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/00498250600683197"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1080\/00498250600683262"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-013-0089-y"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.70068"},{"key":"e_1_2_9_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.curtheres.2019.01.007"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200645090-00005"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.2317"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248-025-01151-5"},{"key":"e_1_2_9_16_1","unstructured":"CDC National Center for Health Statistics \u201cNHANES Questionaires Datasets and Related Documents \u201d2026 accessed March 18 2026 https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/."},{"key":"e_1_2_9_17_1","unstructured":"CDC National Center for Health Statistics \u201cWHO Growth Standards for Use in US Infants and Children Birth to 2\u2009Years \u201d2006 accessed 18 2026 https:\/\/www.cdc.gov\/growthcharts\/who\u2010growth\u2010charts.htm."},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.585"},{"key":"e_1_2_9_19_1","unstructured":"N.Izat V.Shakhnovich K.Kyler J.Leeder T.Johnson andA.Galatin \u201cAddressing Obesity and Demographic Variability in Pediatric Pantoprazole Pharmacokinetics via Virtual Twin PBPK Modelling \u201d2025 ISSX Chicago USA."},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.5055\/jom.2012.0119"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2022.01.1291"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.1089\/104454603321666199"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199912163412502"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e318040b29e"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.1177\/00912700122012832"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1177\/00912709922008434"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.12144"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270008321811"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.25575"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1047951115000359"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.17"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-6143.2003.00077.x"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.3525"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics17111413"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40262-025-01573-6"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1778"},{"key":"e_1_2_9_37_1","unstructured":"International Conference on Harmonisation \u201cAddendum to ICH E11: Clinical Investigation of Medicinal Products in the Pediatric Population \u201d2017 ICH accessed February 02 2026 https:\/\/database.ich.org\/sites\/default\/files\/E11_R1_Addendum.pdf."},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13532"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.3578"},{"key":"e_1_2_9_40_1","unstructured":"US Food and Drug Administration (FDA) Guidance for Industry: E17 General Principles for Planning and Design of Multi\u2010Regional Clinical Trials2018 acessed February 02 2026 https:\/\/www.fda.gov\/regulatory\u2010information\/search\u2010fda\u2010guidance\u2010documents\/e17\u2010general\u2010principles\u2010planning\u2010and\u2010design\u2010multi\u2010regional\u2010clinical\u2010trials."},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15385"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.13.94"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1249"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.clpt.6100275"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2493080468"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.20179"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.409"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270009360533"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.70135"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dmpk.2025.101514"}],"container-title":["CPT: Pharmacometrics &amp; Systems Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/psp4.70344","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/psp4.70344","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/psp4.70344","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:18:11Z","timestamp":1792066691000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/psp4.70344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1002\/psp4.70344"],"URL":"https:\/\/doi.org\/10.1002\/psp4.70344","archive":["Portico"],"relation":{},"ISSN":["2163-8306","2163-8306"],"issn-type":[{"value":"2163-8306","type":"print"},{"value":"2163-8306","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]},"assertion":[{"value":"2026-04-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70344"}}